| Filed On | Filing |
|---|---|
| 11 Apr 2006 | Form 3: Nomura International Plc, 10% owner and 3 others · Gyre Therapeutics, Inc. |
| 26 Jan 2006 |
Form 3: Nomura International Plc, 10% owner and 1 other · Altus Pharmaceuticals Inc.
Holds 2,317,639 shares of Series B Convertible Preferred Shares |
| 26 Aug 2005 |
Form 3: Nomura International Plc, 10% owner and 3 others · Acadia Pharmaceuticals Inc.
Holds 2,199,010 shares of Common Stock, par value $0.0001 per share ("Common Stock") |
| 17 Aug 2001 | Form 3 |
| 07 Dec 1998 | Form 3 |
Loading...
